Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

Bermuda College is celebrating 30 years of partnership with Roche Bermuda, a leading subsidiary of the global healthcare ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Roche Diagnostics has said early diagnosis through Human Papillomavirus (HPV) testing could alleviate financial pressures on ...

The countdown to Super Bowl LIX between the Kansas City Chiefs and Philadelphia Eagles has begun! Join us for the latest ...

Dan Roche offers up a plan for the Red Sox to go out and sign Alex Bregman, which he believes would solidify Boston as a ...

Roche has secured a new FDA approval for its first companion diagnostic test aimed at identifying breast cancer patients with ...

Novo Nordisk has bolstered the case for its near-approval hemophilia A drug candidate Mim8, linking the prospect to ...

Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The ...

Can David Roche break Jim Walmsley’s record of 14:09:28 at the Western States 100 this year? He thinks he’s in with a chance. It’s fair to say that a lot of us hadn’t heard of Roche before last summer ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...